Home
>
US Stocks
>
Poseida Therapeutics Inc
Poseida Therapeutics Inc
PSTX

Poseida Therapeutics Inc

$6.5834.27%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.52
Today Low/High
6.43 / 6.68
52 Week Low/High
$7.63 / $13.98
Market Cap
$574.76M

Company Details

Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing its proprietary genetic engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. Poseida has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core proprietary platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ site-specific gene editing system and nanoparticle- and AAV-based gene delivery technologies. Its core platform technologies have utility, either alone or in combination, across many cell and gene therapeutic modalities and enable Poseida Therapeutics to engineer its wholly-owned portfolio of product candidates that are designed to overcome the primary limitations of current generation cell and gene therapeutics.
Organisation
Poseida Therapeutics Inc
Headquaters
San Diego, California, US
Employees
206
Industry
Health Technology
CEO
Eric Ostertag

Discover more

Frequently Asked Questions

What is Poseida Therapeutics Inc share price today

Can Indians buy Poseida Therapeutics Inc shares?

How can I buy Poseida Therapeutics Inc shares from India?

Can Fractional shares of Poseida Therapeutics Inc be purchased?

What are the documents required to start investing in Poseida Therapeutics Inc stocks?

We are a SEBI registered investement advisor